Acute kidney injury (AKI) is a major health problem, affecting >1.5 million patients in the US each year. AKI is a precursor to chronic kidney disease and often progresses to kidney failure. Currently there are no effective treatments for AKI and therapies are urgently needed. The kidney has an inherent ability to regenerate following injury, raising the possibility that pro-regenerative therapies for AKI can be developed. Renal regeneration is thought to occur by surviving renal tubular epithelial cells (RTECs) undergoing dedifferentiation to a progenitor-like state followed by proliferation and re-differentiation. In addition, M1/'kill' (classic/pro- inflammatory) and M2/'heal' (alternative/pro-repair) type macrophages play opposing roles in promoting tubular regeneration, respectively, and the balance of these subtypes is critical for healthy repair. For poorly understood reasons, the regenerative process can stall, with RTECs arresting in the G2/M phase of the cell cycle and producing pro-fibrotic cytokines. Therefore, finding drugs that promote tubular repair and reduce fibrosis will have a tremendous clinical impact. Towards this goal, we have developed zebrafish and induced pluripotent stem cell (iPSC)-derived human kidney organoids as models to study AKI and we have identified novel pro-regenerative compounds. We discovered a new class of histone deacetylase (HDAC) inhibitors (HDIs), the phenylthiobutanoates (PTBAs), which specifically inhibit HDAC8, a known modulator of retinoic acid (RA) signaling. We have demonstrated that PTBAs promote renal regeneration by increasing proliferation and decreasing G2/M arrest of zebrafish and mouse RTECs, and reduce post-AKI fibrosis in mice. We discovered that these pro-regenerative activities are dependent on RA signaling during AKI. Studies suggest that RA acts on RTECs as well as macrophages to alter M1/M2 switching and reduce RTEC G2/M arrest. Based on these data, we hypothesize that PTBAs promote renal regeneration by inhibiting HDAC8, thereby enhancing RA signaling, which in turn, induces RTEC proliferation and alters M1/M2 macrophage switching. To test these hypotheses, we propose the following Aims:
Aim 1. Elucidate the role of Retinoic Acid and HDAC8 in driving PTBA efficacy. The focus is to confirm HDAC8 as the in vivo target of PTBA, explore the effect of PTBA on the RA pathway, and perform an unbiased RNA-Seq screen to identify RTEC genes affected by PTBA treatment.
Aim 2. Examine the relationship between PTBA and the immune response in zebrafish. Our data suggests that RA signaling drives M2/'heal' polarization, we favor a model in which PTBA enhances RA signaling in macrophages, thereby promoting M2/'heal'-mediated renal repair.
Aim 3. Establish human kidney organoids as a model of AKI and pre-clinical drug testing. We have developed a simple bioreactor- based method for generating, in bulk, human kidney organoids from iPSCs for modeling AKI.
Acute kidney injury (AKI) is a common disorder with high mortality but there are no specific treatments in humans. We have identified a family of compounds (PTBAs) that promote recovery from AKI and we hypothesize that they act by enhancing retinoic acid, a naturally occurring pro-regenerative, anti-inflammatory molecule. The goal of our study is to test this hypothesis and to better understand the therapeutic basis of PTBAs so that these lead compounds can be advanced into clinical trials.
| Espiritu, Eugenel B; Crunk, Amanda E; Bais, Abha et al. (2018) The Lhx1-Ldb1 complex interacts with Furry to regulate microRNA expression during pronephric kidney development. Sci Rep 8:16029 |
| Han, Hwa I; Skvarca, Lauren B; Espiritu, Eugenel B et al. (2018) The role of macrophages during acute kidney injury: destruction and repair. Pediatr Nephrol : |
| Wen, Xiaoyan; Cui, Liyan; Morrisroe, Seth et al. (2018) A zebrafish model of infection-associated acute kidney injury. Am J Physiol Renal Physiol 315:F291-F299 |
| Cerqueira, Débora M; Bodnar, Andrew J; Phua, Yu Leng et al. (2017) Bim gene dosage is critical in modulating nephron progenitor survival in the absence of microRNAs during kidney development. FASEB J 31:3540-3554 |
| Skrypnyk, Nataliya I; Sanker, Subramaniam; Skvarca, Lauren Brilli et al. (2016) Delayed treatment with PTBA analogs reduces postinjury renal fibrosis after kidney injury. Am J Physiol Renal Physiol 310:F705-F716 |
| Chiba, Takuto; Skrypnyk, Nataliya I; Skvarca, Lauren Brilli et al. (2016) Retinoic Acid Signaling Coordinates Macrophage-Dependent Injury and Repair after AKI. J Am Soc Nephrol 27:495-508 |
| Naylor, Richard W; Skvarca, Lauren Brilli; Thisse, Christine et al. (2016) BMP and retinoic acid regulate anterior-posterior patterning of the non-axial mesoderm across the dorsal-ventral axis. Nat Commun 7:12197 |
| Cirio, Maria Cecilia; de Caestecker, Mark P; Hukriede, Neil A (2015) Zebrafish Models of Kidney Damage and Repair. Curr Pathobiol Rep 3:163-170 |
| Chiba, Takuto; Hukriede, Neil; de Caestecker, Mark P (2015) Kidney Regeneration: Lessons from Development. Curr Pathobiol Rep 3:67-79 |
| Diep, Cuong Q; Peng, Zhenzhen; Ukah, Tobechukwu K et al. (2015) Development of the zebrafish mesonephros. Genesis 53:257-69 |
Showing the most recent 10 out of 34 publications
